Research and Development
Established in 1999, we strongly value the importance of nurturing a working culture of innovation.
-
20 % +of Revenue Invested in R&D
-
2,631Global Patent Applications have been Filed（As of 31 December 2025）
-
22Leading or Participating in the Development of 22 Domestic and International Standards of Medical Devices（As of April 2026）
News
LifeTech News
LifeTech Scientific Corporation Announces 2025 Annual Results: Steady Revenue Growth with Adjusted Net Profit Increasing 24.9%
2026 / 03 / 31
More Details
LifeTech News
LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased
LifeTech Scientific Corporation, a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its unaudited consolidated results for the six months ended 30 June 2025.
2025 / 08 / 29
More Details
LifeTech News
LifeTech Scientific Corporation Announced 2024 Annual Results：Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%
LifeTech Scientific Corporation, a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiariesannounced the audited consolidated results for the year ended 31 December 2024.
2025 / 03 / 28
More Details
LifeTech News
LifeTech Scientific Corporation Announced 2023 Annual Results：International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development
LifeTech Scientific Corporation (the “Company” or “Lifetech”, Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiaries announced the audited consolidated results for the year ended 31 December 2023.
2024 / 04 / 02
More Details
LifeTech News
LifeTech Scientific Corporation Announced 2024 Interim Results：International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%
LifeTech Scientific Corporation (the “Company” or “LifeTech”, Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiaries (the “Group”) announced the consolidated results for the six months ended 30 June 2024 (the “Reporting Period”).
2024 / 08 / 30
More Details
Join Us
Becoming a globally-recognized, trustworthy and innovative
interventional medical device enterprise
Contact Us
interventional medical device enterprise
